Here is your NEWS-Line for Radiology Professionals eNewsletter. For the latest news, jobs, education and blogs, bookmark our news page and job board or to take us everywhere with you, save this link to your phone. Also, enjoy the latest issue of NEWS-Line magazine, always free.
NEWS:
ACR Marks Centennial With Unveiling Of New Brand
The American College of Radiology® (ACR®) unveiled its new brand as a centerpiece of its first 100-year celebration at ACR 2023, the College’s annual meeting in Washington, DC. Featuring the theme — “Focused. Forward. Together.” — the new ACR branding will roll out during the next several weeks.
“Celebrating its centennial year, ACR’s new branding is bold, inclusive and forward-thinking,” said Jacqueline A. Bello, MD, FACR, chair, ACR Board of Chancellors. “The new branding, which includes a new logo and tagline, captures the College’s position as a champion for radiology and emphasizes that ACR will have significant impact on every member’s future and ability to care for our patients.”
“The College helps shape the profession, the industry and the future of radiology, and this new branding is a reflection of those efforts,” said William T. Thorwarth Jr., MD, FACR, CEO of ACR. “While h
Read Full Article
Cancer Stage And Receptor Status Indicate A Breast Cancer Survivor’s Risk Of Recurrence
New research indicates that for patients with breast cancer, the cancer’s stage and receptor status can help clinicians predict whether and when cancer might recur after initial treatment. The findings are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.
For the study, Heather Neuman, MD, MS, of the University of Wisconsin, and her colleagues analyzed data on 8,007 patients with stage I–III breast cancer who participated in nine clinical trials from 1997–2013 and received standard of care therapy.
Time to first cancer recurrence varied significantly between cancers with different receptors—including estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). Within each receptor type, cancer stage influenced time to recurrence.
Risk of recurrence was highest and occurred earliest for ER−/PR−
Read Full Article
How Electricity Can Heal Wounds Three Times As Fast
Chronic wounds are a major health problem for diabetic patients and the elderly – in extreme cases they can even lead to amputation. Using electric stimulation, researchers in a project at Chalmers University of Technology, Sweden, and the University of Freiburg, Germany, have developed a method that speeds up the healing process, making wounds heal three times faster.
There is an old Swedish saying that one should never neglect a small wound or a friend in need. For most people, a small wound does not lead to any serious complications, but many common diagnoses make wound healing far more difficult. People with diabetes, spinal injuries or poor blood circulation have impaired wound healing ability. This means a greater risk of infection and chronic wounds – which in the long run can lead to such serious consequences as amputation.
Now a group of researchers at Chalmers and the Unive
Read Full Article
Can We Intercept Cancer? A New Frontier in Cancer Research
Imagine cancer as a line on a chalkboard. At the left is a healthy cell. Reading left to right, you can follow a cell’s journey as it begins to develop abnormalities, morphs to become a localized cancer, and finally metastasizes to an advanced cancer at the far side of the spectrum. “As a field, we’ve been spending a lot of time looking to the right. The opportunity now is to look to the left,” says Robert Vonderheide, MD, DPhil, director of the University of Pennsylvania’s Abramson Cancer Center and the John H. Glick Abramson Cancer Center Professor in the Perelman School of Medicine. “Can we intercept those precursor lesions before they become cancer?”
That is the promise of the burgeoning field of cancer interception. The goal of interception is to catch, or intercept, cancer cells as they begin to develop into pre-cancers or very early cancers, and halt or reverse that process. The
